[go: up one dir, main page]

UA97011U - METHOD OF TREATMENT OF WOMEN WITH PATHOLOGICAL PRELIMINARY PERIOD - Google Patents

METHOD OF TREATMENT OF WOMEN WITH PATHOLOGICAL PRELIMINARY PERIOD

Info

Publication number
UA97011U
UA97011U UAU201410475U UAU201410475U UA97011U UA 97011 U UA97011 U UA 97011U UA U201410475 U UAU201410475 U UA U201410475U UA U201410475 U UAU201410475 U UA U201410475U UA 97011 U UA97011 U UA 97011U
Authority
UA
Ukraine
Prior art keywords
women
treatment
days
once
preliminary period
Prior art date
Application number
UAU201410475U
Other languages
Russian (ru)
Ukrainian (uk)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to UAU201410475U priority Critical patent/UA97011U/en
Publication of UA97011U publication Critical patent/UA97011U/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Спосіб лікування жінок з патологічним прелімінарним періодом включає застосування лікарських засобів. На тлі базової терапії додатково призначають гініпрал - 5 мг в 100 мл фізичного розчину внутрішньовенно крапельно протягом 30 хвилин (0,15 мкг на хвилину) одноразово на добу, протягом 2-х днів. Далі вводять істенон - 2 мл в 100 мл фізичного розчину внутрішньовенно крапельно один раз на добу протягом 2-х днів. Далі глутаргін - 10 мл 4 % розчину в 100 мл фізичного розчину внутрішньовенно крапельно одноразово протягом 2-х днів.A method of treating women with a pathological pre-liminary period involves the use of medicines. Against the background of basic therapy, gipripral is prescribed - 5 mg in 100 ml of physical solution intravenously drip for 30 minutes (0.15 μg per minute) once a day, for 2 days. Next is injected Istenon - 2 ml in 100 ml of physical solution intravenously, once a day for 2 days. Then glutargine - 10 ml of 4% solution in 100 ml of physical solution intravenously drip once for 2 days.

UAU201410475U 2014-09-25 2014-09-25 METHOD OF TREATMENT OF WOMEN WITH PATHOLOGICAL PRELIMINARY PERIOD UA97011U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201410475U UA97011U (en) 2014-09-25 2014-09-25 METHOD OF TREATMENT OF WOMEN WITH PATHOLOGICAL PRELIMINARY PERIOD

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201410475U UA97011U (en) 2014-09-25 2014-09-25 METHOD OF TREATMENT OF WOMEN WITH PATHOLOGICAL PRELIMINARY PERIOD

Publications (1)

Publication Number Publication Date
UA97011U true UA97011U (en) 2015-02-25

Family

ID=52990088

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201410475U UA97011U (en) 2014-09-25 2014-09-25 METHOD OF TREATMENT OF WOMEN WITH PATHOLOGICAL PRELIMINARY PERIOD

Country Status (1)

Country Link
UA (1) UA97011U (en)

Similar Documents

Publication Publication Date Title
MX2021004821A (en) Methods of cancer treatment with antagonists against pd-1 and pd-l1 in combination with radiation therapy.
MX2023005014A (en) Methods of treating chronic inflammatory diseases.
ZA201704327B (en) Methods and compositions for treating brain diseases
MY203831A (en) Treatment and diagnosis of inflammatory disorders
AR095594A1 (en) METHODS TO TREAT INFECTIONS IN PATIENTS WITH OVERWEIGHT AND OBESOS USING ANTIBIOTICS
EA202193276A1 (en) METHODS FOR THE TREATMENT OF CHOLANGIOCARCINOMA
MX2019004804A (en) Treatment of prurigo nodularis.
MX2020007222A (en) Minocycline for treating inflammatory skin conditions.
MY200803A (en) Mpo inhibitors for use in medicine
MX2021014120A (en) Treatment of androgen deprivation therapy associated symptoms.
UA97011U (en) METHOD OF TREATMENT OF WOMEN WITH PATHOLOGICAL PRELIMINARY PERIOD
MX385725B (en) PHARMACEUTICAL COMPOSITION INCLUDING SUMATRIPTAN FOR THE TREATMENT OF MIGRAINE.
MX2016002139A (en) Pharmaceutical composition and use of diethyl (2-cyanoethyl)phosphonate.
RU2012115039A (en) METHOD FOR TREATING CHRONIC ENDOMETRITIS
EA201590325A1 (en) IMPROVED CANCER TREATMENT WITH REDUCED RENAL TOXICITY
UA114982U (en) METHOD OF TREATMENT OF PATIENTS WITH CHRONIC PURPLE EXTREMELY SYNUIT WITH TYPE 1 DIABETES
UA96488U (en) A method for treating disorders of hemovascular hemostasis in patients with ischemic heart disease
UA97663U (en) METHOD OF TREATMENT OF VERTEBROGENIC PAIN SYNDROME IN PATIENTS WITH MULTIPLE SCLEROSIS
UA97449U (en) Method for treatment of urogenital infections in patients with psoriasis arthropica
UA94167U (en) Method for improving the treatment of thyrotoxic cardiomyopathy
UA96506U (en) METHOD OF TREATMENT OF NEUROPATHIES
MX2016010919A (en) 4-benzylsulfonyl-2-butenenitrile.
UA98863U (en) Method for treating endometrial hyperplasia of patients of reproductive age
UA98493U (en) A method of treating transient ischemic attack
UA93361U (en) METHOD OF TREATMENT OF OPIATES OF OPIATE ABSTRINENT SYNDROME